Primer Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 5


  • Investments
  • 15

  • Portfolio
  • 10

  • Exits
  • 4


Primer Capital General Information

Company Description

Founded in 2015, Primer Capital is a venture capital firm based in Moscow, Russia. The firm seeks to invest in companies operating in the healthcare, pharmaceutical and biotech industries having projects in oncology, cardiology, rheumatology, surgery, or any other areas.

Business Details

Year Founded
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 10 Ostozhenka
  • Ostozhenka Office Building
  • Moscow, 119034
  • Russia
+7 8 (000) 000-00-00

Primer Capital Investments (15)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Nelo 14-Sep-2021 Early Stage VC 0000 Financial Software Generating Revenue
Botkin.AI 23-Dec-2020 00000 00000 00.000 Other Healthcare Technology Systems Generating Revenue
Athira Pharma 04-Jun-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2
Mindera Health 14-Nov-2019 00000 00000 00.000 Other Healthcare Technology Systems Generating Revenue
Acticor Biotech 06-Nov-2019 00000 00000 000.00 Biotechnology Clinical Trials - Phase 3 000000000 0000000000000000
Botkin.AI 28-May-2019 00000 00000 00.000 Other Healthcare Technology Systems Generating Revenue
Target Medicals Group 09-Oct-2017 00000 00000 00000 Drug Discovery Generating Revenue 000000000 0000000000000000
Bendit 01-Sep-2017 00000 00000 00.000 Surgical Devices Clinical Trials - General
GemoPharm 31-Aug-2017 Early Stage VC Drug Discovery Out of Business 000000000 0000000000000000
Botkin.AI 08-Mar-2017 Early Stage VC 00000 Other Healthcare Technology Systems Generating Revenue
You’re viewing 10 of 15 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Primer Capital Exits (4)

Company Name Exit Date Exit Type Exit Size
GemoPharm 01-Feb-2023 Out of Business
FK Laboratoriz 26-May-2022 0000000000: 000000
Acticor Biotech 01-Nov-2021 IPO 0000
Athira Pharma 18-Sep-2020 IPO 00000
To view Primer Capital’s complete exits history, request access »

Primer Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Primer Capital Management, Team & Partners (13)

Name Title Deals Funds Boards Office
Anton Lavrentev Chief Executive Officer Moscow, Russia
Timur Avdeenko Founder, Managing Partner & Investment committee member 0 Moscow, Russia
Olga Tsyuryupa Investment Director Moscow, Russia
Nadezhda Kartashova Ph.D Advisor Moscow, Russia
Vadim Tarasov Advisory Board Member Moscow, Russia
You’re viewing 5 of 13 team members. Get the full list »

Primer Capital Co-Investors (37)

Name With Exits Lead Partner Series Industry
Citadel Enterprise Americas 1 0 Series chart Industry bar
Franklin Templeton 0 0 Series chart Industry bar
Kayne Anderson Capital Advisors 0 0 0 Series chart Industry bar
Sofinnova Investments 0 0 Series chart Industry bar
Venrock 0 0 Series chart Industry bar
You’re viewing 5 of 37 co-investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »